Diabetic nephropathy screening
|
Diabetic nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diabetic nephropathy screening On the Web |
|
American Roentgen Ray Society Images of Diabetic nephropathy screening |
|
Risk calculators and risk factors for Diabetic nephropathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
Microalbumin levels in the urine is an excellent tool to look for early damage to kidneys secondary to diabetes. Albumin is a protein found normally in the serum, but it gets completely absorbed from the renal tubules when it is filtered into the nephron from the glomerulus. Hence, a damaged nephron will not reabsorb the albumin filtered by the glomerulus and it appears in the urine.
Screening
- Screening for nephropathy in diabetes should begin at the time of diagnosis of type II diabetes mellitus, since about 7% of patients may have damaged kidneys even in early stages of diabetes.
- Minute levels of albumin (microalbuminuria) in the urine are not detectable with routine urine protein dipsticks.
- The incidence of diabetic nephropathy may particularly increase in patients with poor glycemic control, systemic hypertension and hyperlipidemia.
- If microalbuminuria is not present, the test must be repeated annually for both type I and type II diabetes mellitus patients.
- There are two ways to screen patients for diabetic nephropathy:
- Spot urine sample test
- 24 hour and timed urine collection
- The spot urine sample collection is preferred as it is convenient to perform and has a high sensitivity as well as specificity. The 24 hour and timed urine collection method is cumbersome and is inaccurate because of improper urine collection techniques and timing.
- The albumin levels in the urine can be recorded in two ways:
- As concentration (in mg/dl)
- As a ratio (albumin : creatinine ratio)